SCHEMBL2804823

SCHEMBL2804823

CCCc1ccc2c(c1C(=O)O)Cc1ccccc1O2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.42
MAOB P27338 1/20 0.42
ACSL1 P33121 1/20 0.37
PTPN1 P18031 1/20 0.36
PTPN11 Q06124 1/20 0.36
BID P55957 3/20 0.36
MCL1 Q07820 3/20 0.36
PPARA Q07869 3/20 0.36
BCL2L1 Q07817 2/20 0.36
BAK1 Q16611 2/20 0.36
KAT8 Q9H7Z6 2/20 0.36
PPARG P37231 2/20 0.36
EP300 Q09472 1/20 0.36
KAT2A Q92830 1/20 0.36
KAT2B Q92831 1/20 0.36
KAT5 Q92993 1/20 0.36
SAE1 Q9UBE0 1/20 0.36
CA12 O43570 1/20 0.35
ALOX5 P09917 2/20 0.34
PTGS1 P23219 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL135629 0.92 BID (0.43) MAOAMAOBBIDMCL1PPARA
SCHEMBL2313646 0.90 MAOA (0.46) MAOAMAOBACSL1ALOX5PTGS1
SCHEMBL2811299 0.90 BID (0.50) BIDMCL1PPARABCL2L1BAK1
SCHEMBL2197127 0.90 BID (0.50) BIDMCL1PPARABCL2L1BAK1
SCHEMBL2501503 0.90 BID (0.50) BIDMCL1PPARABCL2L1BAK1
SCHEMBL9055787 0.90 BID (0.50) BIDMCL1PPARABCL2L1BAK1
Potassium SCHEMBL4602990 0.89 MAOA (0.44) MAOAMAOBACSL1ALOX5PTGS1
SCHEMBL16563060 0.89 MAOA (0.44) MAOAMAOBACSL1ALOX5PTGS1
Ammonia Solution, Strong SCHEMBL11609491 0.89 BID (0.49) BIDMCL1PPARABCL2L1BAK1
Zinc Ion SCHEMBL15157997 0.88 MAOA (0.39) MAOAMAOBACSL1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112536157-B Beneficiation method for high-carbon refractory lead-zinc ore 矿冶科技集团有限公司 2022-07-01 CN claimed
CN-113333149-A Beneficiation method for aggregate stubborn stibnite 西北矿冶研究院 2021-09-03 CN claimed
CN-112536157-A Beneficiation method for high-carbon refractory lead-zinc ore 矿冶科技集团有限公司 2021-03-23 CN claimed
CN-112536157-B Beneficiation method for high-carbon refractory lead-zinc ore 矿冶科技集团有限公司 2022-07-01 CN disclosed
CN-113333149-A Beneficiation method for aggregate stubborn stibnite 西北矿冶研究院 2021-09-03 CN disclosed
CN-112536157-A Beneficiation method for high-carbon refractory lead-zinc ore 矿冶科技集团有限公司 2021-03-23 CN disclosed
US-8435966-B2 Associations of xanthogenates and cyclodextrins, and their use BIOSPHINGS AG (DE) 2013-05-07 US disclosed
US-20100240606-A1 ASSOCIATIONS OF XANTHOGENATES AND CYCLODEXTRINS, AND THEIR USE BIOSPHINGS AG (DE) 2010-09-23 US disclosed
EP-0098974-A1 Material for forming a joint between two bodies at the outer sides of their interfaces; processes to realize these unities MICHELIN & CIE (Compagnie Générale des Etablissements Michelin) Société dite: (FR) 1984-01-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240606-A1 ASSOCIATIONS OF XANTHOGENATES AND CYCLODEXTRINS, AND THEIR USE HLA-DRB1, CXCR3, ANTXR2 MAOA 3881/4885MAOB 4358/4885ACSL1 2876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.